CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2018 Financial Results

NEXT STORY
Chembio Diagnostics to Report Fourth Quarter and Full Year 2018 Financial Results on March 7, 2019
PREV STORY
TYME Receives FDA Guidance on Pivotal Trial for SM-88 in Treatment for Advanced Pancreatic Cancer
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Loxo Oncology Announces Accepted Abstracts at the IASLC 19th World Conference on Lung Cancer

STAMFORD, Conn., Aug. 10, 2018 (GLOBE NEWSWIRE) -- Loxo Oncology, Inc. (Nasdaq:LOXO), a biopharmaceutical ...

author_avatar
NASDAQ Market News

ADMA Biologics Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares

RAMSEY, N.J., May 03, 2016 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ:ADMA), a late-stage ...

author_avatar
NASDAQ Market News

Bavarian Nordic Announces USD 100 Million Supply Contract for IMVAMUNE Smallpox Vaccine with the U.S. Government

New order affirms the U.S. Government commitment to freeze-dried IMVAMUNE COPENHAGEN, Denmark, May 19, 2016 ...

author_avatar
NASDAQ Market News